Cargando…
Comparative Analysis of Vaccine Inequity and COVID-19 Transmission Amid the Omicron Variant Among Countries — Six Countries, Asia-Pacific Region, 2022
WHAT IS ALREADY KNOWN ABOUT THIS TOPIC? The coronavirus disease 2019 (COVID-19) persists as a significant global public health crisis. The predominant strain, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), notably the Omicron variant, continues to undergo mutations. While vaccination...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10468375/ https://www.ncbi.nlm.nih.gov/pubmed/37663898 http://dx.doi.org/10.46234/ccdcw2023.139 |
_version_ | 1785099226229768192 |
---|---|
author | Yang, Jingli McClymont, Hannah Warne, David J. Wang, Liping Hu, Wenbiao |
author_facet | Yang, Jingli McClymont, Hannah Warne, David J. Wang, Liping Hu, Wenbiao |
author_sort | Yang, Jingli |
collection | PubMed |
description | WHAT IS ALREADY KNOWN ABOUT THIS TOPIC? The coronavirus disease 2019 (COVID-19) persists as a significant global public health crisis. The predominant strain, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), notably the Omicron variant, continues to undergo mutations. While vaccination is heralded as the paramount solution to cease the pandemic, challenges persist in providing equitable access to COVID-19 vaccines. WHAT IS ADDED BY THIS REPORT? The distribution of vaccine coverage exhibited disparities between high-income and middle-income countries, with middle-income countries evidencing lower levels of vaccination. The data further suggested that countries with lesser vaccination levels tended to display a higher case fatality rate. Findings indicated that an increase in population-wide vaccination was effective in mitigating COVID-19 related mortalities. WHAT ARE THE IMPLICATIONS FOR PUBLIC HEALTH PRACTICE? The findings of this research underscore the pressing necessity for equitable access to vaccines to effectively mitigate the COVID-19 pandemic within the Asia-Pacific region. |
format | Online Article Text |
id | pubmed-10468375 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-104683752023-09-01 Comparative Analysis of Vaccine Inequity and COVID-19 Transmission Amid the Omicron Variant Among Countries — Six Countries, Asia-Pacific Region, 2022 Yang, Jingli McClymont, Hannah Warne, David J. Wang, Liping Hu, Wenbiao China CDC Wkly Preplanned Studies WHAT IS ALREADY KNOWN ABOUT THIS TOPIC? The coronavirus disease 2019 (COVID-19) persists as a significant global public health crisis. The predominant strain, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), notably the Omicron variant, continues to undergo mutations. While vaccination is heralded as the paramount solution to cease the pandemic, challenges persist in providing equitable access to COVID-19 vaccines. WHAT IS ADDED BY THIS REPORT? The distribution of vaccine coverage exhibited disparities between high-income and middle-income countries, with middle-income countries evidencing lower levels of vaccination. The data further suggested that countries with lesser vaccination levels tended to display a higher case fatality rate. Findings indicated that an increase in population-wide vaccination was effective in mitigating COVID-19 related mortalities. WHAT ARE THE IMPLICATIONS FOR PUBLIC HEALTH PRACTICE? The findings of this research underscore the pressing necessity for equitable access to vaccines to effectively mitigate the COVID-19 pandemic within the Asia-Pacific region. Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2023-08-18 /pmc/articles/PMC10468375/ /pubmed/37663898 http://dx.doi.org/10.46234/ccdcw2023.139 Text en Copyright and License information: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2023 https://creativecommons.org/licenses/by-nc-sa/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/) |
spellingShingle | Preplanned Studies Yang, Jingli McClymont, Hannah Warne, David J. Wang, Liping Hu, Wenbiao Comparative Analysis of Vaccine Inequity and COVID-19 Transmission Amid the Omicron Variant Among Countries — Six Countries, Asia-Pacific Region, 2022 |
title | Comparative Analysis of Vaccine Inequity and COVID-19 Transmission Amid the Omicron Variant Among Countries — Six Countries, Asia-Pacific Region, 2022 |
title_full | Comparative Analysis of Vaccine Inequity and COVID-19 Transmission Amid the Omicron Variant Among Countries — Six Countries, Asia-Pacific Region, 2022 |
title_fullStr | Comparative Analysis of Vaccine Inequity and COVID-19 Transmission Amid the Omicron Variant Among Countries — Six Countries, Asia-Pacific Region, 2022 |
title_full_unstemmed | Comparative Analysis of Vaccine Inequity and COVID-19 Transmission Amid the Omicron Variant Among Countries — Six Countries, Asia-Pacific Region, 2022 |
title_short | Comparative Analysis of Vaccine Inequity and COVID-19 Transmission Amid the Omicron Variant Among Countries — Six Countries, Asia-Pacific Region, 2022 |
title_sort | comparative analysis of vaccine inequity and covid-19 transmission amid the omicron variant among countries — six countries, asia-pacific region, 2022 |
topic | Preplanned Studies |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10468375/ https://www.ncbi.nlm.nih.gov/pubmed/37663898 http://dx.doi.org/10.46234/ccdcw2023.139 |
work_keys_str_mv | AT yangjingli comparativeanalysisofvaccineinequityandcovid19transmissionamidtheomicronvariantamongcountriessixcountriesasiapacificregion2022 AT mcclymonthannah comparativeanalysisofvaccineinequityandcovid19transmissionamidtheomicronvariantamongcountriessixcountriesasiapacificregion2022 AT warnedavidj comparativeanalysisofvaccineinequityandcovid19transmissionamidtheomicronvariantamongcountriessixcountriesasiapacificregion2022 AT wangliping comparativeanalysisofvaccineinequityandcovid19transmissionamidtheomicronvariantamongcountriessixcountriesasiapacificregion2022 AT huwenbiao comparativeanalysisofvaccineinequityandcovid19transmissionamidtheomicronvariantamongcountriessixcountriesasiapacificregion2022 |